- Stocks
- Healthcare
- NASDAQ: AMGN

Price (delayed)

$216.94

Market cap

$126.3B

P/E Ratio

17.37

Dividend/share

$6.25

EPS

$12.49

Enterprise value

$151.5B

The P/E is 28% below the 5-year quarterly average of 24.1 and 6% below the last 4 quarters average of 18.5

The revenue has grown by 7% year-on-year and by 2.8% since the previous quarter

AMGN's quick ratio is down by 28% year-on-year but it is up by 3.1% since the previous quarter

The debt rose by 15% year-on-year

The net income has contracted by 9% YoY

What are the main financial stats of AMGN

Market
Valuations
Earnings

Shares outstanding

582.17M

Market cap

$126.3B

Enterprise value

$151.5B

Price to earnings (P/E)

17.37

Price to book (P/B)

11.59

Price to sales (P/S)

5.08

EV/EBIT

15.97

EV/EBITDA

11.73

EV/Sales

6.06

Revenue

$24.99B

EBIT

$9.48B

EBITDA

$12.91B

Free cash flow

$10.24B

Per share
Balance sheet
Liquidity

EPS

$12.49

Free cash flow per share

$17.5

Book value per share

$18.71

Revenue per share

$42.71

TBVPS

$55.91

Total assets

$64.64B

Total liabilities

$53.68B

Debt

$34.29B

Equity

$10.96B

Working capital

$12.71B

Debt to equity

3.13

Current ratio

2.28

Quick ratio

1.65

Net debt/EBITDA

1.95

Margins
Efficiency
Dividend

EBITDA margin

51.7%

Gross margin

76.7%

Net margin

29.4%

Operating margin

36.7%

Return on assets

11.7%

Return on equity

72.1%

Return on invested capital

22%

Return on capital employed

17.3%

Return on sales

38%

Dividend yield

2.88%

DPS

$6.25

Payout ratio

50%

How has the Amgen stock price performed over time

How have Amgen's revenue and profit performed over time

Revenue

$24.99B

Gross profit

$19.17B

Operating income

$9.18B

Net income

$7.35B

Gross margin

76.7%

Net margin

29.4%

The net margin has declined by 15% year-on-year and by 2% since the previous quarter

The company's operating margin fell by 14% YoY and by 3.2% QoQ

The net income has contracted by 9% YoY

AMGN's operating income is down by 8% year-on-year

What is Amgen's growth rate over time

What is Amgen stock price valuation

P/E

17.37

P/B

11.59

P/S

5.08

EV/EBIT

15.97

EV/EBITDA

11.73

EV/Sales

6.06

The P/E is 28% below the 5-year quarterly average of 24.1 and 6% below the last 4 quarters average of 18.5

AMGN's EPS is down by 4.7% year-on-year

The stock's price to book (P/B) is 47% more than its 5-year quarterly average of 7.9 but 14% less than its last 4 quarters average of 13.5

Amgen's equity has increased by 2.8% from the previous quarter

The P/S is 11% less than the last 4 quarters average of 5.7 and 6% less than the 5-year quarterly average of 5.4

The revenue has grown by 7% year-on-year and by 2.8% since the previous quarter

How efficient is Amgen business performance

AMGN's return on sales is down by 17% year-on-year and by 3.6% since the previous quarter

AMGN's return on assets is down by 9% year-on-year

The ROIC has grown by 9% YoY but it has contracted by 2.2% from the previous quarter

What is AMGN's dividend history

DPS

$6.25

Dividend yield

2.88%

Payout ratio

50%

Recent dividends

How did Amgen financials performed over time

Amgen's total assets is 20% more than its total liabilities

AMGN's quick ratio is down by 28% year-on-year but it is up by 3.1% since the previous quarter

Amgen's current ratio has decreased by 21% YoY but it has increased by 4.6% from the previous quarter

AMGN's debt to equity is up by 15% YoY but it is down by 2.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.